The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to ...

The Federal Trade Commission has announced what it called a “landmark settlement” with Express Scripts over insulin pricing.

The agreement announced Wednesday includes sweeping changes to the Cigna PBM’s business practices, including no longer ...

The Federal Trade Commission has reached a landmark settlement with Express Scripts, one of the nation’s largest pharmacy ...

Express Scripts agreed to overhaul its business model, ensuring patients pay the lowest available price for medications and ...

Cigna Corp's Express Scripts settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated ...

The settlement comes after the FTC in September 2024 brought action against three prescription drug benefit managers, including Express Scripts, alleging the companies were artificially inflating the ...

According to Express Scripts, its new pharmacy benefits model, first announced in October 2025, could lower brand name ...

The legislation will impose new restrictions on pharmacy benefit managers, giant companies like CVS Caremark, Optum Rx and ...

Express Scripts’ FTC settlement over insulin pricing is expected to save consumers $7B over 10 years. Read more here.

The Federal Trade Commission (FTC) has secured a landmark settlement with one of the nation’s largest pharmacy benefit ...

The FTC settled a lawsuit against Express Scripts over allegations that the company artificially inflated the price of insulin and impeded access to treatment.